Bifunctional antibiotic hybrids: A review of clinical candidates

Antibiotic resistance is a top threat to human health and a priority across the globe. This problematic issue is accompanied by the decline of new antibiotics in the pipeline over the past 30 years. In this context, an urgent need to develop new strategies to combat antimicrobial resistance is in gr...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology 2023-06, Vol.14, p.1158152-1158152
Main Authors: Koh, Augustine Jing Jie, Thombare, Varsha, Hussein, Maytham, Rao, Gauri G, Li, Jian, Velkov, Tony
Format: Article
Language:English
Subjects:
antibiotic pipeline
antibiotic resistance
drug combinations
drug synthesis
hybrid antibiotics
Pharmacology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c469t-7d3684140b1193d7a494019767ca5bba59ef1188f8f4ee039f28324d443742313
cites cdi_FETCH-LOGICAL-c469t-7d3684140b1193d7a494019767ca5bba59ef1188f8f4ee039f28324d443742313
container_end_page 1158152
container_issue
container_start_page 1158152
container_title Frontiers in pharmacology
container_volume 14
creator Koh, Augustine Jing Jie
Thombare, Varsha
Hussein, Maytham
Rao, Gauri G
Li, Jian
Velkov, Tony
description Antibiotic resistance is a top threat to human health and a priority across the globe. This problematic issue is accompanied by the decline of new antibiotics in the pipeline over the past 30 years. In this context, an urgent need to develop new strategies to combat antimicrobial resistance is in great demand. Lately, among the possible approaches used to deal with antimicrobial resistance is the covalent ligation of two antibiotic pharmacophores that target the bacterial cells through a dissimilar mode of action into a single hybrid molecule, namely hybrid antibiotics. This strategy exhibits several advantages, including better antibacterial activity, overcoming the existing resistance towards individual antibiotics, and may ultimately delay the onset of bacterial resistance. This review sheds light on the latest development of the dual antibiotic hybrids pipeline, their potential mechanisms of action, and challenges in their use.
doi_str_mv 10.3389/fphar.2023.1158152
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ed517d4f7d70407991ecf69ae72cf14d</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_ed517d4f7d70407991ecf69ae72cf14d</doaj_id><sourcerecordid>2832843199</sourcerecordid><originalsourceid>FETCH-LOGICAL-c469t-7d3684140b1193d7a494019767ca5bba59ef1188f8f4ee039f28324d443742313</originalsourceid><addsrcrecordid>eNpVkU1PGzEQhq0KVFDgD_RQ7bGXBI89u7Z7KRSVDwmJCz1bXn8Qo806tTdU_Ps6JEXgiy175plXfgj5AnTBuVRnYb00ecEo4wuAVkLLPpFj6Do-VxLYwbvzETkt5YnWxZXiHX4mR1xwJVDKY3L-M4bNaKeYRjM0ZpxiH9MUbbN86XN05Xtz0WT_HP3fJoXGDnGMthZaM7rozOTLCTkMZij-dL_PyO-rXw-XN_O7--vby4u7ucVOTXPheCcRkPYAijthUCEFJTphTdv3plU-AEgZZEDva9LAJGfoELlAxoHPyO2O65J50uscVya_6GSifr1I-VGbXIMPXnvXgnAYhBMUqVAKvA2dMl4wGwBdZf3YsdabfuWd9eOUzfAB-vFljEv9mJ410JoEaVsJ3_aEnP5sfJn0Khbrh8GMPm2K3oaXyKF--IywXanNqZTsw9scoHqrUr-q1FuVeq-yNn19n_Ct5b84_g_9Wpos</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2832843199</pqid></control><display><type>article</type><title>Bifunctional antibiotic hybrids: A review of clinical candidates</title><source>PubMed Central (PMC)</source><creator>Koh, Augustine Jing Jie ; Thombare, Varsha ; Hussein, Maytham ; Rao, Gauri G ; Li, Jian ; Velkov, Tony</creator><creatorcontrib>Koh, Augustine Jing Jie ; Thombare, Varsha ; Hussein, Maytham ; Rao, Gauri G ; Li, Jian ; Velkov, Tony</creatorcontrib><description>Antibiotic resistance is a top threat to human health and a priority across the globe. This problematic issue is accompanied by the decline of new antibiotics in the pipeline over the past 30 years. In this context, an urgent need to develop new strategies to combat antimicrobial resistance is in great demand. Lately, among the possible approaches used to deal with antimicrobial resistance is the covalent ligation of two antibiotic pharmacophores that target the bacterial cells through a dissimilar mode of action into a single hybrid molecule, namely hybrid antibiotics. This strategy exhibits several advantages, including better antibacterial activity, overcoming the existing resistance towards individual antibiotics, and may ultimately delay the onset of bacterial resistance. This review sheds light on the latest development of the dual antibiotic hybrids pipeline, their potential mechanisms of action, and challenges in their use.</description><identifier>ISSN: 1663-9812</identifier><identifier>EISSN: 1663-9812</identifier><identifier>DOI: 10.3389/fphar.2023.1158152</identifier><identifier>PMID: 37397488</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>antibiotic pipeline ; antibiotic resistance ; drug combinations ; drug synthesis ; hybrid antibiotics ; Pharmacology</subject><ispartof>Frontiers in pharmacology, 2023-06, Vol.14, p.1158152-1158152</ispartof><rights>Copyright © 2023 Koh, Thombare, Hussein, Rao, Li and Velkov.</rights><rights>Copyright © 2023 Koh, Thombare, Hussein, Rao, Li and Velkov. 2023 Koh, Thombare, Hussein, Rao, Li and Velkov</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c469t-7d3684140b1193d7a494019767ca5bba59ef1188f8f4ee039f28324d443742313</citedby><cites>FETCH-LOGICAL-c469t-7d3684140b1193d7a494019767ca5bba59ef1188f8f4ee039f28324d443742313</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313405/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313405/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27922,27923,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37397488$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Koh, Augustine Jing Jie</creatorcontrib><creatorcontrib>Thombare, Varsha</creatorcontrib><creatorcontrib>Hussein, Maytham</creatorcontrib><creatorcontrib>Rao, Gauri G</creatorcontrib><creatorcontrib>Li, Jian</creatorcontrib><creatorcontrib>Velkov, Tony</creatorcontrib><title>Bifunctional antibiotic hybrids: A review of clinical candidates</title><title>Frontiers in pharmacology</title><addtitle>Front Pharmacol</addtitle><description>Antibiotic resistance is a top threat to human health and a priority across the globe. This problematic issue is accompanied by the decline of new antibiotics in the pipeline over the past 30 years. In this context, an urgent need to develop new strategies to combat antimicrobial resistance is in great demand. Lately, among the possible approaches used to deal with antimicrobial resistance is the covalent ligation of two antibiotic pharmacophores that target the bacterial cells through a dissimilar mode of action into a single hybrid molecule, namely hybrid antibiotics. This strategy exhibits several advantages, including better antibacterial activity, overcoming the existing resistance towards individual antibiotics, and may ultimately delay the onset of bacterial resistance. This review sheds light on the latest development of the dual antibiotic hybrids pipeline, their potential mechanisms of action, and challenges in their use.</description><subject>antibiotic pipeline</subject><subject>antibiotic resistance</subject><subject>drug combinations</subject><subject>drug synthesis</subject><subject>hybrid antibiotics</subject><subject>Pharmacology</subject><issn>1663-9812</issn><issn>1663-9812</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkU1PGzEQhq0KVFDgD_RQ7bGXBI89u7Z7KRSVDwmJCz1bXn8Qo806tTdU_Ps6JEXgiy175plXfgj5AnTBuVRnYb00ecEo4wuAVkLLPpFj6Do-VxLYwbvzETkt5YnWxZXiHX4mR1xwJVDKY3L-M4bNaKeYRjM0ZpxiH9MUbbN86XN05Xtz0WT_HP3fJoXGDnGMthZaM7rozOTLCTkMZij-dL_PyO-rXw-XN_O7--vby4u7ucVOTXPheCcRkPYAijthUCEFJTphTdv3plU-AEgZZEDva9LAJGfoELlAxoHPyO2O65J50uscVya_6GSifr1I-VGbXIMPXnvXgnAYhBMUqVAKvA2dMl4wGwBdZf3YsdabfuWd9eOUzfAB-vFljEv9mJ410JoEaVsJ3_aEnP5sfJn0Khbrh8GMPm2K3oaXyKF--IywXanNqZTsw9scoHqrUr-q1FuVeq-yNn19n_Ct5b84_g_9Wpos</recordid><startdate>20230612</startdate><enddate>20230612</enddate><creator>Koh, Augustine Jing Jie</creator><creator>Thombare, Varsha</creator><creator>Hussein, Maytham</creator><creator>Rao, Gauri G</creator><creator>Li, Jian</creator><creator>Velkov, Tony</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230612</creationdate><title>Bifunctional antibiotic hybrids: A review of clinical candidates</title><author>Koh, Augustine Jing Jie ; Thombare, Varsha ; Hussein, Maytham ; Rao, Gauri G ; Li, Jian ; Velkov, Tony</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c469t-7d3684140b1193d7a494019767ca5bba59ef1188f8f4ee039f28324d443742313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>antibiotic pipeline</topic><topic>antibiotic resistance</topic><topic>drug combinations</topic><topic>drug synthesis</topic><topic>hybrid antibiotics</topic><topic>Pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koh, Augustine Jing Jie</creatorcontrib><creatorcontrib>Thombare, Varsha</creatorcontrib><creatorcontrib>Hussein, Maytham</creatorcontrib><creatorcontrib>Rao, Gauri G</creatorcontrib><creatorcontrib>Li, Jian</creatorcontrib><creatorcontrib>Velkov, Tony</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koh, Augustine Jing Jie</au><au>Thombare, Varsha</au><au>Hussein, Maytham</au><au>Rao, Gauri G</au><au>Li, Jian</au><au>Velkov, Tony</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bifunctional antibiotic hybrids: A review of clinical candidates</atitle><jtitle>Frontiers in pharmacology</jtitle><addtitle>Front Pharmacol</addtitle><date>2023-06-12</date><risdate>2023</risdate><volume>14</volume><spage>1158152</spage><epage>1158152</epage><pages>1158152-1158152</pages><issn>1663-9812</issn><eissn>1663-9812</eissn><abstract>Antibiotic resistance is a top threat to human health and a priority across the globe. This problematic issue is accompanied by the decline of new antibiotics in the pipeline over the past 30 years. In this context, an urgent need to develop new strategies to combat antimicrobial resistance is in great demand. Lately, among the possible approaches used to deal with antimicrobial resistance is the covalent ligation of two antibiotic pharmacophores that target the bacterial cells through a dissimilar mode of action into a single hybrid molecule, namely hybrid antibiotics. This strategy exhibits several advantages, including better antibacterial activity, overcoming the existing resistance towards individual antibiotics, and may ultimately delay the onset of bacterial resistance. This review sheds light on the latest development of the dual antibiotic hybrids pipeline, their potential mechanisms of action, and challenges in their use.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>37397488</pmid><doi>10.3389/fphar.2023.1158152</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1663-9812
ispartof Frontiers in pharmacology, 2023-06, Vol.14, p.1158152-1158152
issn 1663-9812
1663-9812
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_ed517d4f7d70407991ecf69ae72cf14d
source PubMed Central (PMC)
subjects antibiotic pipeline
antibiotic resistance
drug combinations
drug synthesis
hybrid antibiotics
Pharmacology
title Bifunctional antibiotic hybrids: A review of clinical candidates
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T11%3A35%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bifunctional%20antibiotic%20hybrids:%20A%20review%20of%20clinical%20candidates&rft.jtitle=Frontiers%20in%20pharmacology&rft.au=Koh,%20Augustine%20Jing%20Jie&rft.date=2023-06-12&rft.volume=14&rft.spage=1158152&rft.epage=1158152&rft.pages=1158152-1158152&rft.issn=1663-9812&rft.eissn=1663-9812&rft_id=info:doi/10.3389/fphar.2023.1158152&rft_dat=%3Cproquest_doaj_%3E2832843199%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c469t-7d3684140b1193d7a494019767ca5bba59ef1188f8f4ee039f28324d443742313%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2832843199&rft_id=info:pmid/37397488&rfr_iscdi=true